SYNTHESIS OF HIGH PURE TICAGRELOR, AN ANTIPLATELET DRUG SUBSTANCE AND ITS POSSIBLE PROCESS RELATED IMPURITIES
Author(s) -
S. Venkat Rao,
Rajeev K. Dubey,
Ch. Anil Kumar,
Manasa Reddy,
M. Narendar,
Ramesh Babu Potluri
Publication year - 2018
Publication title -
rasayan journal of chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.281
H-Index - 22
eISSN - 0976-0083
pISSN - 0974-1496
DOI - 10.31788/rjc.2018.1133070
Subject(s) - ticagrelor , drug , antiplatelet drug , pharmacology , medicine , business , aspirin , clopidogrel
S. Venkat Rao, Rajeev Kumar Dubey, Ch. Anil Kumar, M. Sudheer Reddy, M. Narendar and Ramesh Babu Potluri SMS Pharmaceuticals Ltd, R&D Center (A DSIR Approved), Gagillapur (V), Telangana state-500043, India. *E-mail: venkat@smspharma.com; svr.org@gmail.com ABSTRACT Cost effective, robust manufacturing process is developed for N-alkylation of compound 6 and 7 with commercially available reagent/base like DBU, TEA and ethanol used as a solvent. The most important development is high pure pharma product Ticagrelor was achieved by purifying in mixture of Methanol and Water. As per ICH guidelines all known and unknown impurities limits below NMT 0.10% achieved with excellent yield (75%) and Quality 99.9%.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom